NCT02221505 Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02193958 Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02160600 Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial Status COMPLETED Phase NA
NCT02152956 Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE1/PHASE2
NCT02039726 (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive Status COMPLETED Phase PHASE3
NCT01994837 A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE2
NCT01690507 Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML) Status COMPLETED Phase PHASE1/PHASE2
NCT01570465 Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients Status TERMINATED Phase N/A
NCT01532635 A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Status TERMINATED Phase PHASE2
NCT01449058 A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01319864 POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Status COMPLETED Phase PHASE1
NCT01268800 Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy Status UNKNOWN Phase N/A
NCT01261312 SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT01204164 Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01188174 Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure Status COMPLETED Phase PHASE2
NCT01184898 Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) Status COMPLETED Phase NA